Associate Professor, Medicine, Tufts Medical Center
Cardiology
Dr. Carey Kimmelstiel, MD
|
|
Give Review
Carey Kimmelstiel, MD is an expert in the field of Cardiology. He researched medicine at State University of New York Downstate Medical Center College of Medicine. He received 4 awards: "America's Top Doctors", "Boston Magazine", "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACC)". Carey Kimmelstiel is a published doctor. He published 61 publications, including: 'Infectious causes of atherosclerosis.' He accepts all Medicare patients.
Publications
- Thrombin inhibition during PCI in Heart failure patients.
- Quantitative assessment of myocardial perfusion using time-density curve analysis after elective percutaneous Coronary intervention.
- Alcohol septal ablation versus surgical myectomy for HCM--the controversy continues.
- Twenty-year analysis of trends in the incidence and in-hospital mortality for lower-extremity arterial thromboembolism.
- Aortic valve calcification and the performance of TAVI: Bad actor or part of the scenery?
- Use of intraprocedural CT imaging to guide alcohol septal ablation. Combining complementary imaging modalities.
- The effect of differing pharmacologic strategies on infarct size in Primary PCI-more confirmatory data for bivalirudin.
- The American Health Security Act.
- Recurrent Angina due to a left internal mammary artery-to-pulmonary artery fistula.
- Effects of renal neutral endopeptidase inhibition on sodium excretion, renal hemodynamics and neurohormonal activation in patients with congestive Heart failure.
- Infectious causes of atherosclerosis.
- In-hospital approach to newly recognized Atrial fibrillation.
- Antiplatelet therapy in interventional cardiology: I. Newer oral antiplatelet agents.
- Antiplatelet therapy in interventional cardiology: II. Glycoprotein IIb/IIIa inhibitors.
- Definitive balloon catheter sizing in totally occluded Coronary arteries.
- Pharmacodynamics and pharmacokinetics of the platelet GPIIb/IIIa inhibitor tirofiban in patients undergoing percutaneous Coronary intervention: implications for adjust...
- Conversion of infarction-associated Atrial fibrillation by restoration of Atrial perfusion.
- The Occluded Artery Trial (OAT) Viability Ancillary Study (OAT-NUC): Influence of infarct zone viability on left ventricular remodeling after percutaneous Coronary int...
- Images in clinical medicine. Mitral stenosis.
- Short-term comparative outcomes associated with the use of GP IIb/IIIa antagonists in patients undergoing Coronary intervention.
- Congestive Heart failure in women: focus on Heart failure due to coronary artery disease and diabetes.
- Rapid enzyme measurements in patients with suspected Acute myocardial infarction.
- How effective is digitalis in the treatment of congestive Heart failure?
- Use of sequential cardiac enzyme analysis in stratification of risk for myocardial infarction in patients with unstable Angina.
- Identification of risk factors for development of acute myocardial infarction or life-threatening ventricular arrhythmia in unstable Angina pectoris.
- Primary angioplasty of an anomalous left main Coronary artery: diagnostic and technical considerations.
- Statin use is associated with enhanced collateralization of severely diseased Coronary arteries.
- Images in cardiovascular medicine. Primary lymphoma of the Heart.
- Hospital cost effect of a Heart failure disease management program: the Specialized Primary and Networked Care in Heart Failure (SPAN-CHF) trial.
- Occlusion of a large Coronary-cameral fistula using the Amplatzer vascular plug in a 2-year old.
- Multislice computed tomography after left main drug-eluting stenting: are we putting the cart before the horse?
- Randomized, controlled evaluation of short- and long-term benefits of Heart failure disease management within a diverse provider network: the SPAN-CHF trial.
- Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial).
- Is Patent foramen ovale closure effective in reducing migraine symptoms? A controlled study.
- Aspergillus prosthetic valve endocarditis causing functional Aortic stenosis: initial case report.
- Implications of the mechanical (PCI) vs thrombolytic controversy for ST segment elevation Myocardial infarction on the organization of emergency medical services: the ...
- Blood loss following invasive cardiac procedures: Going beyond the CBC.
- [Alcohol septal ablation and hypertrophic Cardiomyopathy].
- Reducing arrhythmic complications following alcohol septal ablation--the utility of lower doses of ethanol.
- Percutaneous relief of valvular and subvalvular Aortic stenosis.
- Long-term follow-up of the First In Man experience with everolimus-eluting stents.
- Closing one hole leads to another: delayed Aortic perforation following closure of a patent foramen ovale.
- Here today, gone tomorrow: percutaneous closure of Atrial septal defects utilizing a bioabsorbable device.
- Alcohol septal ablation in young children: addressing large gradients in little people.
- Device closure of Patent foramen ovale--do similar devices achieve similar results?
- Autopsy validation study of the academic research consortium stent thrombosis definition.
- Competing pharmacological strategies during PCI-analysis of a prematurely terminated trial.
- Alcohol septal ablation via a subendocardial approach: Acute effects in an animal model.
- Restrictions on interactions between doctors and industry could ultimately hurt patients.
- Confined distally: a novel method for retrieving a trapped burr.
- Retrieval of a trapped burr using the mother and child technique.
- Bivalirudin is a dual inhibitor of thrombin and collagen-dependent platelet activation in patients undergoing percutaneous Coronary intervention.
- Elevated soluble fms-like tyrosine kinase-1 levels in Acute coronary occlusion.
- Usefulness of soluble endoglin as a noninvasive measure of left ventricular filling pressure in Heart failure.
- Intracardiac chloroma.
- Extended-release niacin reduces LDL particle number without changing total LDL cholesterol in patients with stable CAD.
- Effects of extended-release niacin on lipoprotein particle size, distribution, and inflammatory markers in patients with Coronary artery disease.
- Role of percutaneous septal ablation in hypertrophic obstructive Cardiomyopathy.
- Treatment of in-stent restenosis for saphenous vein grafts using intravascular brachytherapy: regulatory challenges and clinical application.
- Heart failure in women.
Schools
Suny Downstate Medical Center
Kings Co HospUniv Hospital SUNY
Tufts University New Eng Med Center
University Mass
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Ectasia
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- BlueConnect HMO
- Blue with Managed Care Behavioral Health HMO
- Preferred Blue PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- Fallon Community Health Plan
- First Health (Coventry Health Care) PPO
- Harvard Pilgrim Health Care PPO
- Medicare Advantage PFFS
- Choice Care PPO
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Network Health
- Simplifi
- Tufts Health Plans
- Tufts PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- America's Top Doctors
- Boston Magazine
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACC)
Education
-
University of Massachusetts -
SUNY Health Science Center at Brooklyn -
State University of New York Downstate Medical Center College of Medicine
Hospital
-
Tufts Medical Center
Drug Facts
| NPI NUMBER | 1043326713 | |
| NPPES Provider LastName | KIMMELSTIEL | |
| NPPES Provider FirstName | CAREY | |
| NPPES Provider ZIPCode | 021111526 | |
| NPPES Provider State | MA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 380.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1043326713 |
| Last Name Of The Provider | KIMMELSTIEL |
| First Name Of The Provider | CAREY |
| View All |
Similar Doctors
|
|
Dr. Rahul C. Deo, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer L. Hellawell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Brian G. Hynes, MB BCH
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas Metkus, MD |
|
|
Dr. Kevin J. Croce, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin R. Bainey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert L. Salazar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric Ackah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kathryn A. Britton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Evaldas Giedrimas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William Chutkow, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amer Johri, MD
This Doctor is OpenDoctor Recommended.
|